Author
Nakwon Kwak
Also Known As
Kwak, N., N Kwak, N. Kwak, NAKWON KWAK, Nakwon Kwak
130
Publications
2.5K
Citations
24
H-Index
46
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 9 | 9 | 361 |
2 | Global Health | 2 | 2 | 73 |
3 | Public Health | 1 | 1 | 55 |
4 | Emergency Medicine | 1 | 1 | 12 |
5 | Epidemiology | 1 | 1 | 55 |
Nakwon Kwak
×
37
Publications
1.3K
Citations
21
H-Index
| Year | Citations | |
|---|---|---|
2014 | 105 | |
2020 | 95 | |
2020 | 78 | |
2013 | 70 | |
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea | 2022 | 61 |
2020 | 56 | |
2019 | 55 | |
2020 | 55 | |
2022 | 51 | |
2020 | 45 |
Page 1
Page 1